SCHEMBL23716391

SCHEMBL23716391

C=C(C)Cc1cc(C)on1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.40
RECQL P46063 2/20 0.40
EPHX2 P34913 1/20 0.38
ALDH1A1 P00352 3/20 0.37
EGFR P00533 2/20 0.37
GAA P10253 1/20 0.37
GAPDH P04406 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CYBB P04839 1/20 0.36
NOX5 Q96PH1 1/20 0.36
TRPM8 Q7Z2W7 1/20 0.35
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
NPC1 O15118 2/20 0.34
RAB9A P51151 1/20 0.34
KDM4E B2RXH2 1/20 0.33
POLB P06746 1/20 0.33
HPGD P15428 1/20 0.33
ALOX15 P16050 1/20 0.33
APEX1 P27695 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15719546 0.82 ALDH1A1 (0.43) MAPTRECQLEPHX2ALDH1A1EGFR
SCHEMBL15719919 0.79 MAPT (0.37) MAPTRECQLEPHX2ALDH1A1EGFR
SCHEMBL724170 0.78 ALDH1A1 (0.43) MAPTRECQLEPHX2ALDH1A1EGFR
SCHEMBL691738 0.76 HTT (0.44) MAPTRECQLEPHX2ALDH1A1EGFR
SCHEMBL6965688 0.76 EPHX2 (0.40) MAPTRECQLEPHX2ALDH1A1EGFR
SCHEMBL357108 0.76
SCHEMBL6961965 0.73 NPC1 (0.41) MAPTRECQLEPHX2ALDH1A1EGFR
SCHEMBL2828069 0.73 KDM4E (0.44) MAPTEPHX2ALDH1A1EGFRGAA
SCHEMBL20020213 0.73 ALDH1A1 (0.47) MAPTRECQLEPHX2ALDH1A1EGFR
SCHEMBL171777 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023230540-A2 INDAZOLE DERIVATIVES FOR TREATING TRPM3-MEDIATED DISORDERS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-11-30 WO disclosed
WO-2021154665-A1 1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS BRISTOL-MYERS SQUIBB COMPANY (US) 2021-08-05 WO disclosed